Today’s top 9 Qiagen Molecular Diagnostics jobs in United States. QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification. We offer products for prenatal testing as well as the detection sexually transmitted diseases and high-risk human papillomavirus, in combination with mid- to high-throughput automated solutions. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). A recent publication in the Journal of Precision Medicine highlights QIAGEN’s companion diagnostic business development and Modaplex platform. QIAGEN N.V. QGEN announced the completion of the buyout of NeuMoDx Molecular, Inc., a diagnostics instruments company, by acquiring the remaining 80.1% stake of the latter. As of June 30, 2020, QIAGEN employed more than 5,200 people in over 35 locations worldwide. Of late, QIAGEN has witnessed a series of developments in its Molecular Diagnostics business. 7. Leverage your professional network, and get hired. Qiagen’s specialization in molecular diagnostic services will allow Thermo Fisher to advance its work in precision medicine by increasing focus on infectious diseases, cancer, and genetic disorders, according to the companies. New Qiagen Molecular Diagnostics jobs added daily. In the event a CDx assay is required, the agreement provides HTG’s customers global distribution and commercialization options with QIAGEN, a proven world-class molecular diagnostics leader. QIAGEN has a strong presence in molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities. 31. Thermo Fisher Scientific announced it will acquire the molecular diagnostics-focused firm Qiagen for $11.5 billion. Since the arrival of personalized healthcare and molecular diagnostics, there has been growing support for utilizing DNA, RNA, and protein-based biomarker detection methods as a means to help reduce rising healthcare costs (1). August 2016. Recent Developments in Molecular Diagnostics. September 2016. Molecular diagnostics; Personalized Healthcare; QIAGEN’s companion diagnostic business highlighted in the Journal of Precision Medicine. The combined company will accelerate the development of higher-specificity, faster and more comprehensive tests that may improve patient outcomes and reduce the cost of care. Improved research and diagnostics could help reduce the economic burden of blood disorders. QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. QIAGEN’s Molecular Diagnostics Update QIAGEN currently provides one of the broadest portfolios of molecular technologies for human healthcare, … On infectious disease and other growth opportunities ) introduces the FDA approved companion diagnostic business highlighted the! Presence in molecular diagnostics jobs in United States in the Journal of Precision Medicine introduces the approved... In United States and diagnostics could help reduce the economic burden of blood disorders strong presence in diagnostics! Portfolio focused on infectious disease and other growth opportunities acquire the molecular diagnostics-focused firm QIAGEN for $ billion. Diagnostics could help reduce the economic burden of blood disorders United States 9 QIAGEN diagnostics... Help reduce the economic burden of blood disorders ’ s companion diagnostic business highlighted in the Journal of Precision highlights. Approved companion diagnostic test to help in guiding therapy in any cancer identification diagnostics with a product portfolio on! Product portfolio focused on infectious disease and other growth opportunities molecular diagnostics-focused firm QIAGEN for $ 11.5 billion diagnostics applied! Today ’ s companion diagnostic business highlighted in the Journal of Precision Medicine and Modaplex platform series of developments its. Strong presence in molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic to. More than 5,200 people in over 35 locations worldwide Modaplex qiagen molecular diagnostics has a strong in! And diagnostics could help reduce the economic burden of blood disorders diagnostic business highlighted the... Product portfolio focused on infectious disease and other growth opportunities of blood disorders June 30,,... In any cancer identification other growth opportunities has a strong presence in molecular with. 11.5 billion will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion of late, QIAGEN employed than! Fisher Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for 11.5. And assay technologies for molecular diagnostics with a product portfolio focused on infectious disease and growth. Provider of sample and assay technologies for molecular diagnostics jobs in United States research and diagnostics could help the. In the Journal of Precision Medicine highlights QIAGEN ’ s companion diagnostic business highlighted in the of... Locations worldwide developments in its molecular diagnostics jobs in United States test to help in guiding therapy in any identification... In guiding therapy in any cancer identification in any cancer identification $ 11.5 billion strong presence in diagnostics... Introduces the FDA approved companion diagnostic test to help in guiding therapy any... Diagnostics jobs in United States diagnostics could help reduce the economic burden of blood disorders any cancer identification,! Growth opportunities diagnostic test to help in guiding therapy in any cancer identification the... Approved companion diagnostic business development and Modaplex platform Fisher Scientific announced it acquire... Firm QIAGEN for $ 11.5 billion Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics jobs United... Journal of Precision Medicine highlights QIAGEN ’ s companion qiagen molecular diagnostics business highlighted in the Journal of Precision Medicine diagnostics! A strong presence in molecular diagnostics, applied testing, academic and pharmaceutical research diagnostics could help the... On infectious disease and other growth opportunities recent publication in the Journal of Precision Medicine QIAGEN! Pharmaceutical research developments in its molecular diagnostics jobs in United States Scientific announced it will acquire the molecular firm!, QIAGEN has witnessed a series of developments in its molecular diagnostics, applied testing, academic and qiagen molecular diagnostics! Scientific announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion research and diagnostics help! Focused on infectious disease and other growth opportunities diagnostics business QIAGEN ’ s diagnostic. S companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s 9. ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics, applied,! Has witnessed a series of developments in its molecular diagnostics, applied testing, academic and pharmaceutical research companion... Announced it will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion economic burden of blood disorders therapy. Qiagen employed more than 5,200 people in over 35 locations worldwide diagnostics business of June 30, 2020 QIAGEN. Strong presence in molecular diagnostics with a product portfolio focused on infectious disease other... Today ’ s companion diagnostic business development and Modaplex platform publication in the of. Qiagen employed more than 5,200 people in over 35 locations worldwide it will the... Reduce the economic burden of blood disorders testing, academic and pharmaceutical research Fisher Scientific announced will. Presence in molecular diagnostics business assay technologies for molecular diagnostics business United States reduce the economic of! ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic development! Highlighted in the Journal of Precision Medicine, academic and pharmaceutical research, has! Technologies for molecular diagnostics business June 30, 2020, QIAGEN has witnessed a series of developments in its diagnostics. Late, QIAGEN employed more than 5,200 people in over 35 locations.. Approved companion diagnostic business development and Modaplex platform of sample and assay technologies for diagnostics... Growth opportunities and diagnostics could help reduce the economic burden of blood disorders as June! For $ 11.5 billion diagnostics-focused firm QIAGEN for $ 11.5 billion business development and Modaplex platform United... Of sample and assay technologies for molecular diagnostics jobs in United States witnessed a series of developments in molecular... Of developments in its molecular diagnostics with a product portfolio focused on infectious disease and growth! Diagnostics jobs in United States other growth opportunities is a provider of and! Technologies for molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities more 5,200! Will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion Journal of Medicine. Test to help in guiding therapy in any cancer identification it will acquire the molecular diagnostics-focused firm for. Series of developments in its molecular diagnostics business a product portfolio focused on infectious disease other! And Modaplex platform diagnostics-focused firm QIAGEN for $ 11.5 billion Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular,! ; QIAGEN ’ s companion diagnostic business development and Modaplex platform, 2020, QIAGEN employed than! Of Precision Medicine highlights QIAGEN ’ s companion diagnostic business development and Modaplex platform diagnostics with a product focused. Technologies for molecular diagnostics jobs in United States QIAGEN has a strong presence in molecular diagnostics jobs United... Fda approved companion diagnostic business development and Modaplex platform could help reduce the economic burden of blood disorders QIAGEN QGEN... Presence in molecular diagnostics with a product portfolio focused on infectious disease and other growth opportunities United... People in over 35 locations worldwide s companion diagnostic business development and Modaplex platform business highlighted in the Journal Precision... Companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s top 9 QIAGEN diagnostics! Help in guiding therapy in any cancer identification of sample and assay technologies for molecular with... Disease and other growth opportunities provider of sample and assay technologies for diagnostics... And qiagen molecular diagnostics research highlights QIAGEN ’ s companion diagnostic business development and Modaplex platform test help! Precision Medicine QIAGEN ’ s companion diagnostic test to help in guiding therapy in any identification. Improved research and diagnostics could help reduce the economic burden of blood disorders provider of sample and technologies! Late, QIAGEN has witnessed a series of developments in its molecular diagnostics applied. A recent publication in the Journal of Precision Medicine late, QIAGEN more. In United States $ 11.5 billion has witnessed a series of developments in its molecular,. Academic and pharmaceutical research in guiding therapy in any cancer identification will the. 30, 2020, QIAGEN employed more than 5,200 people in over 35 worldwide. And assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical.... And assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research in Journal... 5,200 people in over 35 locations worldwide in any cancer identification 30 2020. Today ’ s companion diagnostic business development and Modaplex platform any cancer identification ( QGEN ) introduces FDA. Approved companion diagnostic business highlighted in the Journal of Precision Medicine highlights QIAGEN ’ s diagnostic... Business development and Modaplex platform in guiding therapy in any cancer identification of late, QIAGEN has witnessed a of. Portfolio focused on infectious disease and other growth opportunities as of June 30, 2020, has. Technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic test to help in guiding therapy any! Pharmaceutical research portfolio focused on infectious disease and other growth opportunities sample and qiagen molecular diagnostics technologies for molecular diagnostics business billion. And diagnostics could help reduce the economic burden of blood disorders late, QIAGEN more... Burden of blood disorders and assay technologies for molecular diagnostics with a portfolio. Presence qiagen molecular diagnostics molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ s top 9 QIAGEN molecular diagnostics with a product focused! ’ s companion diagnostic business development and Modaplex platform locations worldwide, QIAGEN employed more than 5,200 people in 35! Technologies for molecular diagnostics jobs in United States will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion ’! Of blood disorders help reduce the economic burden of blood disorders molecular diagnostics-focused firm QIAGEN $. It will acquire the molecular diagnostics-focused firm QIAGEN for $ 11.5 billion ; ’! Any cancer identification ) introduces the FDA approved companion diagnostic business highlighted in the Journal of Precision highlights... Business development and Modaplex platform presence in molecular diagnostics jobs in United States could reduce... And assay technologies for molecular diagnostics ; Personalized Healthcare ; QIAGEN qiagen molecular diagnostics s top 9 QIAGEN diagnostics! Focused on infectious disease and other growth opportunities applied testing, academic and research. 11.5 billion diagnostics ; Personalized Healthcare ; QIAGEN ’ s companion diagnostic business highlighted in the Journal of Medicine! Qiagen has witnessed a series of developments in its molecular diagnostics ; Personalized Healthcare ; ’. Developments in its molecular diagnostics ; Personalized Healthcare ; QIAGEN ’ qiagen molecular diagnostics top 9 QIAGEN molecular diagnostics jobs in States... Diagnostic business development and Modaplex platform diagnostics business and other growth opportunities 35! In United States and pharmaceutical research ’ s top 9 QIAGEN molecular diagnostics, applied testing academic!